Research location

Ube

Yamaguchi, Japan

Published trials73
Site observations75
Linked trials published73
Page2 / 2
Advertisement

Research activity in Ube

Yamaguchi, Japan

CureCurrent currently publishes aggregate city-level research activity for this location: 73 trials and 75 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Ube

73 linked trials · page 2 of 2
Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLCNCT02273375 · 2015-02-24 · 1 site observation
COMPLETED
DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Setting in JapanNCT02226822 · 2014-09-20 · 1 site observation
COMPLETED
Efficacy and Safety Study of Darolutamide (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate CancerNCT02200614 · 2014-09-12 · 1 site observation
COMPLETED
Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild SymptomsNCT02043678 · 2014-03-30 · 1 site observation
COMPLETED
The Cardiac Insufficiency BIsoprolol Study in Japanese Patients With Chronic Heart Failure (CIBIS-J)NCT02137733 · 2013-06-01 · 1 site observation
UNKNOWN
Azilsartan Circadian and Sleep PressureNCT01762501 · 2012-12-01 · 1 site observation
COMPLETED
Investigation of the Safety and Efficacy of Iguratimod in Patients With Rheumatoid ArthritisNCT01850966 · 2012-09-12 · 1 site observation
COMPLETED
Inhaled Iloprost (Ventavis): Efficacy, Safety, and Pharmacokinetics (PK) Confirmation StudyNCT01469169 · 2012-06-19 · 1 site observation
COMPLETED
Evaluate Safety as Mono or Combination Therapies With Anti-diabetes Mellitus Drugs in Japanese Subjects With Type 2 Diabetes MellitusNCT01294436 · 2011-02-01 · 1 site observation
COMPLETED
Long Term Safety and Tolerability of QVA149 Versus Tiotropium in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT01285492 · 2011-01-01 · 1 site observation
COMPLETED
Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's DiseaseNCT01251718 · 2010-12-01 · 1 site observation
COMPLETED
Extension Study to Evaluate Safety and Efficacy of Natalizumab in Japanese Participants With Relapsing-Remitting Multiple SclerosisNCT01416155 · 2010-10-01 · 1 site observation
COMPLETED
Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart FailureNCT01115855 · 2010-07-01 · 2 site observations
COMPLETED
Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-NCT01129596 · 2010-06-10 · 1 site observation
COMPLETED
Long Term Safety and Tolerability of NVA237 Versus Tiotropium in Japanese PatientsNCT01119937 · 2010-05-01 · 1 site observation
COMPLETED
Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart FailureNCT00853658 · 2009-03-01 · 1 site observation
COMPLETED
Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive DisorderNCT00798707 · 2008-12-01 · 1 site observation
COMPLETED
Evaluation of Efficacy and Safety of Formoterol in Patients With COPD Compared With Placebo in Patients in Japan, EUNCT00628862 · 2007-12-01 · 1 site observation
COMPLETED
First Line IRESSA™ Versus Carboplatin/Paclitaxel in AsiaNCT00322452 · 2006-03-01 · 1 site observation
COMPLETED
Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With AsthmaNCT00255255 · 2005-11-01 · 1 site observation
COMPLETED
Efficacy & Safety of Symbicort® TURBUHALER® 160/4.5 µg Twice Daily & Pulmicort® TURBUHALER® 200 µg Twice Daily + Theolong® Tablet 200 mg Twice Daily in Japanese Asthmatic PatientsNCT00252785 · 2005-10-01 · 1 site observation
COMPLETED
Iressa 2nd Line Phase III Study in JapanNCT00252707 · 2003-09-01 · 1 site observation
COMPLETED
Benidipine-based Comparison of Angiotensin Receptors, β-blockers, or Thiazide Diuretics in Hypertensive PatientsNCT00135551 · 2003-05-01 · 1 site observation
COMPLETED
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.